Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation
Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation is a paper indexed in PICO Portal from OpenAlex.
How many citations does Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation have?
Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation has 2 citations in the OpenAlex counts PICO Portal stores.
When was Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation published?
Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation has 2025 year in the PICO Portal index.
What is the open-access status of Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation?
Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation has hybrid oa status in the PICO Portal index.
What is the DOI of Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation?
The DOI for Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation is on the source record.
What is the PMID of Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation?
The PMID for Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation is on the source record.
What is the OpenAlex record for Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation?
The OpenAlex for Antidiabetic drugs in Parkinson’s disease: a comprehensive meta-analysis on efficacy and safety with trial sequential analysis and GRADE evaluation is on the source record.